Skip to main content

Advertisement

Table 4 What factors are important in your decision to participate in a clinical trialNumber (%) of patients who agree/strongly agree to survey questions grouped by demographic characteristics of interest

From: Understanding the attitudes of the elderly towards enrolment into cancer clinical trials

  Age Health Status Cancer Status
Question n/N (%) < 75 n/N (%) ≥ 75 p-value n/N (%) Good/Excellent n/N (%) Poor/Marginal/Ave p-value n/N (%) Cured n/N (%) Not Cured p-value
Recommendation from cancer doctor to participate 45/46 (98) 44/47 (94)   45/47 (96) 41/43 (95)   30/31 (97) 46/49 (94)  
   0.32   0.93   0.56
Recommendation from the family doctor to participate 36/46 (78) 40/46 (87)   38/47 (81) 35/42 (83)   25/31 (81) 39/48 (81)  
   0.27   0.76   0.95
Recommendation from family/friends to participate 26/46 (57) 26/45 (58)   24/49 (49) 23/39 (59)   17/31 (55) 28/47 (60)  
   0.90   0.35   0.68
The chance that you may live longer because of the treatment 43/46 (93) 40/46 (87)   41/47 (87) 39/42 (93)   24/31 (77) 46/48 (96)  
   0.29   0.38   0.012
The chance that you may feel better because of the treatment 44/46 (96) 44/46 (96)   45/47 (96) 40/42 (95)   30/31 (97) 45/48 (94)  
   1.00   0.91   0.55
The chance that this study may help other cancer patients in the future 44/45 (98) 43/46 (93)   44/46 (96) 40/42 (95)   30/31 (97) 44/47 (94)  
   0.32   0.93   0.54
Your age 31/44 (70) 28/46 (61)   29/45 (64) 28/42 (67)   20/30 (67) 29/47 (62)  
   0.34   0.83   0.66